https://www.europesays.com/de/1350767/ Wer verdient, wenn Patente fallen? Das Milliardenrennen von Formycon, Fresenius und Pfizer! #Biosimilar #FDA #FreseniusSE&CoKGaA #Investments #Krebstherapie #Meilenstein #Nachfolgerpräparate #Patente #pharma
#biosimilar — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #biosimilar, aggregated by home.social.
-
https://www.europesays.com/ch/145325/ Biocon Secures Key Settlement with Roche for Perjeta Biosimilar Launch by 2027, ETPharma #Biocon #biosimilar #CancerTreatment #Perjeta #Roche